Edatt Lincy, Poyyakkara Aswini, Raji Grace R, Ramachandran Vishnu, Shankar S Sharath, Kumar V B Sameer
Department of Biochemistry and Molecular Biology, Central University of Kerala, Kasaragod, India.
Front Oncol. 2020 Jan 17;9:1516. doi: 10.3389/fonc.2019.01516. eCollection 2019.
Generally, changes in the metabolic status of cells under conditions like hypoxia and accumulation of lactate can be sensed by various sensing mechanisms, leading to modulation of a number of signal transduction pathways and transcription factors. Several of the proangiogenic cytokines like VEGF, FGF, PDGF, TGF-β, Ang-2, ILs, etc. are secreted by cancer cells, under hypoxic microenvironment. These cytokines bind to their receptors on the endothelial cells and activates a number of signaling pathways including Akt/PIP3, Src, p38/MAPK, Smad2/3, etc., which ultimately results in the proliferation and migration of endothelial cells. Transcription factors that are activated in response to the metabolic status of tumors include HIFs, NF-κb, p53, El-2, and FOXO. Many of these transcription factors has been reported to be regulated by a class of histone deacetylase called sirtuins. Sirtuins are NAD dependent histone deacetylases that play pivotal role in the regulation of tumor cell metabolism, proliferation, migration and angiogenesis. The major function of sirtuins include, deacetylation of histones as well as some non-histone proteins like NF-κB, FOXOs, PPAR⋎, PGC1-α, enzymes like acetyl coenzymeA and structural proteins like α tubulin. In the cell, sirtuins are generally considered as the redox sensors and their activities are dependent on the metabolic status of the cell. Understanding the intricate regulatory mechanisms adopted by sirtuins, is crucial in devising effective therapeutic strategies against angiogenesis, metastasis and tumor progression. Keeping this in mind, the present review focuses on the role of sirtuins in the process of tumor angiogenesis and the regulatory mechanisms employed by them.
一般来说,在缺氧和乳酸积累等条件下,细胞代谢状态的变化可通过多种传感机制被感知,从而导致许多信号转导通路和转录因子的调节。一些促血管生成细胞因子,如VEGF、FGF、PDGF、TGF-β、Ang-2、白细胞介素等,是癌细胞在缺氧微环境下分泌的。这些细胞因子与内皮细胞上的受体结合,激活包括Akt/PIP3、Src、p38/MAPK、Smad2/3等在内的多种信号通路,最终导致内皮细胞的增殖和迁移。响应肿瘤代谢状态而被激活的转录因子包括低氧诱导因子(HIFs)、核因子κB(NF-κb)、p53、E1-2和叉头框蛋白O(FOXO)。据报道,这些转录因子中的许多都受一类名为沉默调节蛋白(sirtuins)的组蛋白去乙酰化酶调节。沉默调节蛋白是依赖烟酰胺腺嘌呤二核苷酸(NAD)的组蛋白去乙酰化酶,在肿瘤细胞代谢、增殖、迁移和血管生成的调节中起关键作用。沉默调节蛋白的主要功能包括组蛋白以及一些非组蛋白如NF-κB、FOXO、过氧化物酶体增殖物激活受体γ(PPARγ)、过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC1-α)等酶、乙酰辅酶A等酶和α微管蛋白等结构蛋白的去乙酰化。在细胞中,沉默调节蛋白通常被视为氧化还原传感器,其活性取决于细胞的代谢状态。了解沉默调节蛋白所采用的复杂调节机制,对于设计针对血管生成、转移和肿瘤进展的有效治疗策略至关重要。牢记这一点,本综述重点关注沉默调节蛋白在肿瘤血管生成过程中的作用及其所采用的调节机制。